Anguilla Healthcare Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Anguilla Healthcare Digest.

Press releases published on March 31, 2026

Mar. 31, 2026

Plus Therapeutics Announces Reverse Stock Split 

Indeterminate GlobeNewswire

Mar. 31, 2026

BrightSpring Health Services Completes Sale of ResCare Community Living to Sevita

Indeterminate GlobeNewswire

Mar. 31, 2026

Palvella Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Mar. 31, 2026

MiNK Therapeutics Reports Q4 and Full Year 2025 Results; Phase 2 Programs Advance with Impactful Non-Dilutive Momentum

Indeterminate GlobeNewswire

Mar. 31, 2026

InflaRx Announces Participation in the Raymond James 2026 Biotech Innovation Symposium

Indeterminate GlobeNewswire

Mar. 31, 2026

60 Degrees Pharmaceuticals Announces 2025 Annual Results

Indeterminate GlobeNewswire

Mar. 31, 2026

4basebio announces major expansion to support the growing demand of RUO and HQ synthetic DNA with lease of an innovation hub and manufacturing facility in Cambridge, UK

Indeterminate GlobeNewswire

Mar. 31, 2026

Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders

Indeterminate GlobeNewswire

Mar. 31, 2026

Shock Top Launches High Voltage, Its First-Ever High-ABV Beer

Indeterminate GlobeNewswire

Mar. 31, 2026

Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026

Indeterminate GlobeNewswire

Mar. 31, 2026

Agios Advances Mitapivat Toward Potential U.S. Accelerated Approval in Sickle Cell Disease Following Pre-sNDA Meeting with FDA

Indeterminate GlobeNewswire

Mar. 31, 2026

Biomea Fusion Announces First Patient Dosed in Newly Initiated Phase II Programs Enrolling Type 2 Diabetes Patients Failing on Standard-of-Care Therapies

Indeterminate GlobeNewswire

Mar. 31, 2026

Atos Advances AI-Ready Digital Transformation with Lumen Network as a Service

Indeterminate GlobeNewswire

Mar. 31, 2026

Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology

Indeterminate GlobeNewswire

Mar. 31, 2026

Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology

Indeterminate GlobeNewswire

Mar. 31, 2026

SCYNEXIS Announces $40.0 Million Private Placement

Indeterminate GlobeNewswire

Mar. 31, 2026

SCYNEXIS Completes Transformative Acquisition of PXL-770, an innovative, highly selective, direct AMPK activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Indeterminate GlobeNewswire

Mar. 31, 2026

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Mar. 31, 2026

Beta Bionics Introduces Bionic Insights™ in Bionic Reports — Transforming How Clinicians Understand and Optimize Diabetes Care

Indeterminate GlobeNewswire

Mar. 31, 2026

LENSAR® Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update

Indeterminate GlobeNewswire